Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced the completion of its Phase IIa clinical study for 9MW1911, a self-developed ...

Early detection and innovative biologic treatment can prevent hospitalizations, improve quality of life, and extend the ...

A Chinese Phase IIb trial of the mAb has already started, with Mabwell also hoping to initiate a Phase IIa trial in the US.

Phase 2 trial launched for verekitug in COPD, expanding treatment indications for severe respiratory conditions. Top data expected in 2026. Upstream Bio, Inc. has initiated a global Phase 2 clinical ...

Jul. 1—MORGANTOWN — A new treatment for emphysema is coming to West Virginia. The Zephyr Valve, a treatment classified a medical breakthrough by the Food and Drug Administration, will be offered by ...

There’s no cure for chronic obstructive pulmonary disease (COPD). But there are things you can do to stay active, breathe easier, and live longer -- even if your condition is more advanced. Ask your ...

Milan, Italy: For the first time, researchers have shown it is possible to repair damaged lung tissue in patients with chronic obstructive pulmonary disease (COPD) using the patients’ own lung cells.

She told us her life changed when she sought treatment at Christ Hospital and met Dr. Duane Allen, a pulmonary and critical ...

WHITTIER, Calif., Nov. 19, 2025 /PRNewswire/ -- PIH Health Whittier Hospital is now offering the Zephyr (R) Endobronchial Valve procedure, a breakthrough minimally invasive treatment option for ...

Moderate COPD may mean that physical activity is more difficult, and you may cough up mucus more regularly. People with moderate COPD can take steps to improve their life expectancy by preventing ...

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, today announced the publication of long ...